BMEA Stock Summary and Trading Ideas (Biomea Fusion | NASDAQ:BMEA)

Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System discovery platform to develop a pipeline of novel small-molecule product candidates. Its principal clinical program's drug candidate, icovamenib, is being developed as an orally bioavailable, selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity. The company is also developing BMF-650, an investigational, oral small-molecule GLP-1 RA, which has the potential to be a therapeutic option for diabetes and obesity.

What symbol and exchange does Biomea Fusion shares trade?

Biomea Fusion trades on the NASDAQ stock market under the symbol BMEA.

What is Biomea Fusion stock price doing today?

As of February 20, 2026, BMEA stock price was flat at $1.32 with 740,881 million shares trading.

What is Biomea Fusion's Beta?

BMEA has a beta of 1.48, meaning it tends to be more sensitive to market movements. BMEA has a correlation of 0.06 to the broad based SPY ETF.

How much is Biomea Fusion worth?

BMEA has a market cap of $93.33 million. This is considered a Micro Cap stock.

What is the highest and lowest price Biomea Fusion traded in the last 3 year period?

In the last 3 years, BMEA traded as high as $43.69 and as low as $.87.

What are the top ETFs holding Biomea Fusion?

The top ETF exchange traded funds that BMEA belongs to (by Net Assets): VTI, VXF, IWC.

Is Biomea Fusion (BMEA) a good investment?

BMEA has underperformed the market in the last year with a return of -63.8%, while SPY returned +14.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BMEA shares. However, BMEA has outperformed the market in the last 3 month and 2 week periods, returning +32.0% and +8.2%, while SPY returned +6.0% and -0.2%, respectively. This indicates BMEA has been having a stronger performance recently.

What are the support and resistance levels for Biomea Fusion (BMEA)?

BMEA support price is $1.25 and resistance is $1.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BMEA shares will trade within this expected range on the day.